A-240 PHEOCHROMOCYTOMATOSIS – A RARE DISEASE WITH OMINOUS PROGNOSIS
Sign Up to like & getrecommendations! Published in 2023 at "British Journal of Surgery"
DOI: 10.1093/bjs/znad100.006
Abstract: Pheochromocytomatosis is a rare but dramatic complication of pheochromocytoma surgery. In this study, we collected and analysed our experience with the surgical treatment of cases of this rare condition. In total 9 patients were operated… read more here.
Keywords: time; surgery; disease; pheochromocytomatosis rare ... See more keywords
Pheochromocytomatosis Treated With Peptide Receptor Radionuclide Therapy.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000003973
Abstract: ABSTRACT Pheochromocytomatosis refers to pheochromocytoma tumorlets developed as a result of seeding of tumor cells around the surgical bed due to intraoperative tumor capsule rupture and tumor cell spillage. As pheochromocytomatosis is relatively rare, optimal… read more here.
Keywords: receptor radionuclide; peptide receptor; radionuclide therapy; pheochromocytomatosis ... See more keywords
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of endocrinology"
DOI: 10.1530/eje-21-0797
Abstract: Introduction Recurrent and metastatic pheochromocytoma (PCC) are rare advanced endocrine neoplasms with limited treatment options. Insight into the pathogenic molecular alterations in patients with advanced PCC can provide therapeutic options for precisely targeting dysregulated pathways.… read more here.
Keywords: fusion; braf; pcc; pheochromocytomatosis ... See more keywords